Seizinger Bernd R.
Insider CIK 1789042 · ONCY Director · APRE Director · APTO Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| APTO Aptose Biosciences Inc. | D To issuer deriv | 2026-06-30 | 2026-07-02 | 100,000 | — | $0 | 0 | SEC↗ |
| APTO Aptose Biosciences Inc. | D To issuer deriv | 2026-06-30 | 2026-07-02 | 50,000 | — | $0 | 0 | SEC↗ |
| APTO Aptose Biosciences Inc. | D To issuer deriv | 2026-06-30 | 2026-07-02 | 3,333 | — | $0 | 0 | SEC↗ |
| APTO Aptose Biosciences Inc. | D To issuer | 2026-06-30 | 2026-07-02 | 17,000 | $1.72 | $29.2K | 0 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award deriv | 2026-06-16 | 2026-06-17 | 12,555 | — | $0 | 12,555 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award | 2026-06-16 | 2026-06-17 | 3,135 | — | $0 | 48,910 | SEC↗ |
| ONCY ONCOLYTICS BIOTECH INC | A Award deriv | 2026-06-01 | 2026-06-03 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ONCY ONCOLYTICS BIOTECH INC | P Buy | 2026-02-12 | 2026-02-13 | 40,000 | $0.85 | $34.0K | 566,991 | SEC↗ |
| ONCY ONCOLYTICS BIOTECH INC | P Buy | 2026-02-11 | 2026-02-13 | 60,000 | $0.83 | $49.8K | 526,991 | SEC↗ |
| ONCY ONCOLYTICS BIOTECH INC | P Buy | 2026-01-16 | 2026-01-20 | 100,000 | $1.04 | $104.0K | 466,991 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award deriv | 2025-06-05 | 2025-06-09 | 4,185 | — | $0 | 4,185 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award | 2025-06-05 | 2025-06-09 | 1,045 | — | $0 | 45,775 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | P Buy | 2024-10-11 | 2024-10-15 | 10,000 | $2.68 | $26.8K | 44,730 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award deriv | 2024-06-20 | 2024-06-21 | 4,185 | — | $0 | 4,185 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award | 2024-06-20 | 2024-06-21 | 1,045 | — | $0 | 34,730 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | P Buy deriv | 2024-03-13 | 2024-03-14 | 3,430 | — | $0 | 3,430 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | P Buy deriv | 2024-03-13 | 2024-03-14 | 3,430 | — | $0 | 3,430 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | P Buy | 2024-03-13 | 2024-03-14 | 6,860 | $7.29 | $50.0K | 33,685 | SEC↗ |
| APTO Aptose Biosciences Inc. | A Award deriv | 2024-02-05 | 2024-02-07 | 3,333 | — | $0 | 3,333 | SEC↗ |
| APTO Aptose Biosciences Inc. | P Buy | 2023-09-22 | 2023-09-25 | 17,000 | $3.14 | $53.4K | 17,000 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award deriv | 2023-08-23 | 2023-08-24 | 2,000 | — | $0 | 2,000 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award | 2023-08-23 | 2023-08-24 | 500 | — | $0 | 26,825 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | P Buy | 2023-06-07 | 2023-06-08 | 6,029 | $3.68 | $22.2K | 26,325 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | P Buy | 2023-06-06 | 2023-06-08 | 4,068 | $3.63 | $14.8K | 20,296 | SEC↗ |
| APTO Aptose Biosciences Inc. | A Award deriv | 2023-01-19 | 2023-01-23 | 100,000 | — | $0 | 100,000 | SEC↗ |
| APTO Aptose Biosciences Inc. | A Award deriv | 2022-09-14 | 2022-09-16 | 50,000 | — | $0 | 50,000 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award deriv | 2022-07-28 | 2022-08-01 | 29,575 | — | $0 | 29,575 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award | 2022-07-28 | 2022-08-01 | 5,995 | — | $0 | 324,575 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | P Buy | 2022-05-18 | 2022-05-19 | 50,000 | $0.71 | $35.5K | 318,580 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award deriv | 2021-06-30 | 2021-07-01 | 22,750 | — | $0 | 22,750 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award | 2021-06-30 | 2021-07-01 | 4,610 | — | $0 | 268,580 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award deriv | 2020-06-30 | 2020-07-01 | 5,600 | — | $0 | 5,600 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | M Exercise deriv | 2019-10-07 | 2019-10-07 | 263,970 | — | $0 | 0 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | M Exercise | 2019-10-07 | 2019-10-07 | 263,970 | $0.07 | $18.5K | 263,970 | SEC↗ |